跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Unioxali 50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Unioxali 50
Approved
STANDARD
Unioxali 50
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
46c77870e6471366
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
46c77870e6471366
Drug Approval Philippines Name
Unioxali 50
Product Name
Unioxali 50
Registration Number
DRP-11973
Brand Name
Unioxali 50
Generic Name
Oxaliplatin
Dosage Form
Concentrate Solution for IV Infusion
Dosage Strength
2 mg/mL (50 mg/25 mL)
Manufacturer
Admac Lifesciences
Trader
Unicare Healthsciences Pvt. Ltd.
Importer
AGB Pharmaceutical Trading and Consultancy Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
26 May 2022
Expiry Date
26 May 2027
Pharmacologic Category
Antineoplastic agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
46c77870e6471366
Type
Standard
Back to Philippines FDA Approvals